Maimon Yossi 4
4 · Ayala Pharmaceuticals, Inc. · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Maimon Yossi
CFO
Transactions
- Award
Stock Option
2021-01-04+19,170→ 19,170 totalExercise: $11.26Exp: 2031-01-03→ Common Stock (19,170 underlying) - Award
Common Stock
2021-01-04+8,520→ 19,872 total
Footnotes (1)
- [F1]This option vests and becomes exercisable in sixteen substantially equal quarterly installments from the grants date, such that the option shall be fully vested on January 4, 2025.